BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 15, 2002
View Archived Issues
Orally active acetylcholinesterase and 5-HT uptake inhibitor proposed for Alzheimer's disease
Read More
Protopic cleared for launch in Europe
Read More
GK-04489, a new compound with efficacy in arterial thrombosis and cerebral ischemia
Read More
Findings presented at AAAAI meeting further support development of Genaera's mucoregulator
Read More
BIA-2-024, a new antiepileptic drug, evaluated for metabolism in animals and in vitro
Read More
NeoTherapeutics develops promising new family of antipsychotic drugs
Read More
Potent and selective integrin inhibitors synthesized at Celltech
Read More
First phase I trial of anti-HIV-1 human MAbs assessing safety and pharmacokinetics
Read More
ICAgen research leads to two new series of antiarrhythmic agents
Read More
GSK describes novel fatty acid synthase FabH inhibitors for bacterial infections
Read More
Signal discloses a novel group of JNK inhibitors for a wide range of conditions
Read More
More thrombin inhibitors in development at Merck
Read More
Antitumor activity of AN-238 against human colorectal cancers independent of p53 status
Read More
ISIS-104838 enters second phase II trial in RA
Read More
Collateral Therapeutics gains rights to EPAS1 gene
Read More
Phase I results show Product R to be safe and well tolerated
Read More
Cambrex to manufacture Bioheart's MyoCell therapy
Read More
IL-9 blockade continues to show promise for the treatment of asthma
Read More
Extended-release Zerit has similar virological activity to immediate-release drug
Read More
Risperdal approved for delaying schizophrenia relapse in U.S.
Read More
Trisenox approved in Europe for acute promyelocytic leukemia
Read More
Keryx initiates phase II dosing of KRX-101 in HIV-associated nephropathy
Read More
Third of three phase III trials under way for AC-2993 in treatment of type 2 diabetes
Read More
Bavarian Nordic reviews 2001 progress, 2002 outlook
Read More